世界の個別化がん医療市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Personalized Cancer Medicine Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-4689 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、109ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療

• 販売価格（消費税別）

Single User	￥585,000 (USD3,900)	▷ お問い合わせ
Multi User	￥877,500 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査レポートでは、個別化がん医療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（モノクローナル抗体、個別化がんワクチン、その他）、用途別市場規模（乳がん、肺がん、慢性骨髄性白血病、大腸がん、その他のがん）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・個別化がん医療の市場動向 ・企業の競争状況、市場シェア ・個別化がん医療の種類別市場規模と予測2016-2027（モノクローナル抗体、個別化がんワクチン、その他） ・個別化がん医療の用途別市場規模と予測2016-2027（乳がん、肺がん、慢性骨髄性白血病、大腸がん、その他のがん） ・個別化がん医療の北米市場規模2016-2027（アメリカ、カナダ） ・個別化がん医療の欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・個別化がん医療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・個別化がん医療の中南米市場規模2016-2027（メキシコ、ブラジル） ・個別化がん医療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Abbott、Merck、Novartis、Amgen、Celgene、Bayer、Roche、Astellas、Astrazeneca、Johnson & Johnson、Agilent、Takeda） ・結論

Personalized medicine is at an early stage of development. Scientists found that some cancer cells have particular proteins in the cell and others don’t. Sometimes, cancer cells have far more of a particular protein than healthy cells. Genetic testing of cancer cells and normal cells helps doctors customize treatment to individual patient needs. Personalized treatments may cause fewer side effects than standard options. Some people are already benefiting from this approach.

Market Analysis and Insights: Global Personalized Cancer Medicine Market
The global Personalized Cancer Medicine market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Personalized Cancer Medicine market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Personalized Cancer Medicine market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Personalized Cancer Medicine market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Personalized Cancer Medicine market.

Global Personalized Cancer Medicine Scope and Market Size
Personalized Cancer Medicine market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Personalized Cancer Medicine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Monoclonal Antibodies
Personalized Cancer Vaccines
Other

Segment by Application
Breast Cancer
Lung Cancer
Chronic Myeloid Leukaemia
Bowel Cancer
Other Cancer

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Abbott
Merck
Novartis
Amgen
Celgene
Bayer
Roche
Astellas
Astrazeneca
Johnson & Johnson
Agilent
Takeda

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Personalized Cancer Medicine Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Monoclonal Antibodies
1.2.3 Personalized Cancer Vaccines
1.2.4 Other
1.3 Market by Application
1.3.1 Global Personalized Cancer Medicine Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Breast Cancer
1.3.3 Lung Cancer
1.3.4 Chronic Myeloid Leukaemia
1.3.5 Bowel Cancer
1.3.6 Other Cancer
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Personalized Cancer Medicine Market Perspective (2016-2027)
2.2 Personalized Cancer Medicine Growth Trends by Regions
2.2.1 Personalized Cancer Medicine Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Personalized Cancer Medicine Historic Market Share by Regions (2016-2021)
2.2.3 Personalized Cancer Medicine Forecasted Market Size by Regions (2022-2027)
2.3 Personalized Cancer Medicine Industry Dynamic
2.3.1 Personalized Cancer Medicine Market Trends
2.3.2 Personalized Cancer Medicine Market Drivers
2.3.3 Personalized Cancer Medicine Market Challenges
2.3.4 Personalized Cancer Medicine Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Personalized Cancer Medicine Players by Revenue
3.1.1 Global Top Personalized Cancer Medicine Players by Revenue (2016-2021)
3.1.2 Global Personalized Cancer Medicine Revenue Market Share by Players (2016-2021)
3.2 Global Personalized Cancer Medicine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Personalized Cancer Medicine Revenue
3.4 Global Personalized Cancer Medicine Market Concentration Ratio
3.4.1 Global Personalized Cancer Medicine Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Personalized Cancer Medicine Revenue in 2020
3.5 Personalized Cancer Medicine Key Players Head office and Area Served
3.6 Key Players Personalized Cancer Medicine Product Solution and Service
3.7 Date of Enter into Personalized Cancer Medicine Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Personalized Cancer Medicine Breakdown Data by Type
4.1 Global Personalized Cancer Medicine Historic Market Size by Type (2016-2021)
4.2 Global Personalized Cancer Medicine Forecasted Market Size by Type (2022-2027)

5 Personalized Cancer Medicine Breakdown Data by Application
5.1 Global Personalized Cancer Medicine Historic Market Size by Application (2016-2021)
5.2 Global Personalized Cancer Medicine Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Personalized Cancer Medicine Market Size (2016-2027)
6.2 North America Personalized Cancer Medicine Market Size by Type
6.2.1 North America Personalized Cancer Medicine Market Size by Type (2016-2021)
6.2.2 North America Personalized Cancer Medicine Market Size by Type (2022-2027)
6.2.3 North America Personalized Cancer Medicine Market Size by Type (2016-2027)
6.3 North America Personalized Cancer Medicine Market Size by Application
6.3.1 North America Personalized Cancer Medicine Market Size by Application (2016-2021)
6.3.2 North America Personalized Cancer Medicine Market Size by Application (2022-2027)
6.3.3 North America Personalized Cancer Medicine Market Size by Application (2016-2027)
6.4 North America Personalized Cancer Medicine Market Size by Country
6.4.1 North America Personalized Cancer Medicine Market Size by Country (2016-2021)
6.4.2 North America Personalized Cancer Medicine Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Personalized Cancer Medicine Market Size (2016-2027)
7.2 Europe Personalized Cancer Medicine Market Size by Type
7.2.1 Europe Personalized Cancer Medicine Market Size by Type (2016-2021)
7.2.2 Europe Personalized Cancer Medicine Market Size by Type (2022-2027)
7.2.3 Europe Personalized Cancer Medicine Market Size by Type (2016-2027)
7.3 Europe Personalized Cancer Medicine Market Size by Application
7.3.1 Europe Personalized Cancer Medicine Market Size by Application (2016-2021)
7.3.2 Europe Personalized Cancer Medicine Market Size by Application (2022-2027)
7.3.3 Europe Personalized Cancer Medicine Market Size by Application (2016-2027)
7.4 Europe Personalized Cancer Medicine Market Size by Country
7.4.1 Europe Personalized Cancer Medicine Market Size by Country (2016-2021)
7.4.2 Europe Personalized Cancer Medicine Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Personalized Cancer Medicine Market Size (2016-2027)
8.2 Asia-Pacific Personalized Cancer Medicine Market Size by Type
8.2.1 Asia-Pacific Personalized Cancer Medicine Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Personalized Cancer Medicine Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Personalized Cancer Medicine Market Size by Type (2016-2027)
8.3 Asia-Pacific Personalized Cancer Medicine Market Size by Application
8.3.1 Asia-Pacific Personalized Cancer Medicine Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Personalized Cancer Medicine Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Personalized Cancer Medicine Market Size by Application (2016-2027)
8.4 Asia-Pacific Personalized Cancer Medicine Market Size by Region
8.4.1 Asia-Pacific Personalized Cancer Medicine Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Personalized Cancer Medicine Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Personalized Cancer Medicine Market Size (2016-2027)
9.2 Latin America Personalized Cancer Medicine Market Size by Type
9.2.1 Latin America Personalized Cancer Medicine Market Size by Type (2016-2021)
9.2.2 Latin America Personalized Cancer Medicine Market Size by Type (2022-2027)
9.2.3 Latin America Personalized Cancer Medicine Market Size by Type (2016-2027)
9.3 Latin America Personalized Cancer Medicine Market Size by Application
9.3.1 Latin America Personalized Cancer Medicine Market Size by Application (2016-2021)
9.3.2 Latin America Personalized Cancer Medicine Market Size by Application (2022-2027)
9.3.3 Latin America Personalized Cancer Medicine Market Size by Application (2016-2027)
9.4 Latin America Personalized Cancer Medicine Market Size by Country
9.4.1 Latin America Personalized Cancer Medicine Market Size by Country (2016-2021)
9.4.2 Latin America Personalized Cancer Medicine Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Personalized Cancer Medicine Market Size (2016-2027)
10.2 Middle East & Africa Personalized Cancer Medicine Market Size by Type
10.2.1 Middle East & Africa Personalized Cancer Medicine Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Personalized Cancer Medicine Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Personalized Cancer Medicine Market Size by Type (2016-2027)
10.3 Middle East & Africa Personalized Cancer Medicine Market Size by Application
10.3.1 Middle East & Africa Personalized Cancer Medicine Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Personalized Cancer Medicine Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Personalized Cancer Medicine Market Size by Application (2016-2027)
10.4 Middle East & Africa Personalized Cancer Medicine Market Size by Country
10.4.1 Middle East & Africa Personalized Cancer Medicine Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Personalized Cancer Medicine Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Abbott
11.1.1 Abbott Company Details
11.1.2 Abbott Business Overview
11.1.3 Abbott Personalized Cancer Medicine Introduction
11.1.4 Abbott Revenue in Personalized Cancer Medicine Business (2016-2021)
11.1.5 Abbott Recent Development
11.2 Merck
11.2.1 Merck Company Details
11.2.2 Merck Business Overview
11.2.3 Merck Personalized Cancer Medicine Introduction
11.2.4 Merck Revenue in Personalized Cancer Medicine Business (2016-2021)
11.2.5 Merck Recent Development
11.3 Novartis
11.3.1 Novartis Company Details
11.3.2 Novartis Business Overview
11.3.3 Novartis Personalized Cancer Medicine Introduction
11.3.4 Novartis Revenue in Personalized Cancer Medicine Business (2016-2021)
11.3.5 Novartis Recent Development
11.4 Amgen
11.4.1 Amgen Company Details
11.4.2 Amgen Business Overview
11.4.3 Amgen Personalized Cancer Medicine Introduction
11.4.4 Amgen Revenue in Personalized Cancer Medicine Business (2016-2021)
11.4.5 Amgen Recent Development
11.5 Celgene
11.5.1 Celgene Company Details
11.5.2 Celgene Business Overview
11.5.3 Celgene Personalized Cancer Medicine Introduction
11.5.4 Celgene Revenue in Personalized Cancer Medicine Business (2016-2021)
11.5.5 Celgene Recent Development
11.6 Bayer
11.6.1 Bayer Company Details
11.6.2 Bayer Business Overview
11.6.3 Bayer Personalized Cancer Medicine Introduction
11.6.4 Bayer Revenue in Personalized Cancer Medicine Business (2016-2021)
11.6.5 Bayer Recent Development
11.7 Roche
11.7.1 Roche Company Details
11.7.2 Roche Business Overview
11.7.3 Roche Personalized Cancer Medicine Introduction
11.7.4 Roche Revenue in Personalized Cancer Medicine Business (2016-2021)
11.7.5 Roche Recent Development
11.8 Astellas
11.8.1 Astellas Company Details
11.8.2 Astellas Business Overview
11.8.3 Astellas Personalized Cancer Medicine Introduction
11.8.4 Astellas Revenue in Personalized Cancer Medicine Business (2016-2021)
11.8.5 Astellas Recent Development
11.9 Astrazeneca
11.9.1 Astrazeneca Company Details
11.9.2 Astrazeneca Business Overview
11.9.3 Astrazeneca Personalized Cancer Medicine Introduction
11.9.4 Astrazeneca Revenue in Personalized Cancer Medicine Business (2016-2021)
11.9.5 Astrazeneca Recent Development
11.10 Johnson & Johnson
11.10.1 Johnson & Johnson Company Details
11.10.2 Johnson & Johnson Business Overview
11.10.3 Johnson & Johnson Personalized Cancer Medicine Introduction
11.10.4 Johnson & Johnson Revenue in Personalized Cancer Medicine Business (2016-2021)
11.10.5 Johnson & Johnson Recent Development
11.11 Agilent
11.11.1 Agilent Company Details
11.11.2 Agilent Business Overview
11.11.3 Agilent Personalized Cancer Medicine Introduction
11.11.4 Agilent Revenue in Personalized Cancer Medicine Business (2016-2021)
11.11.5 Agilent Recent Development
11.12 Takeda
11.12.1 Takeda Company Details
11.12.2 Takeda Business Overview
11.12.3 Takeda Personalized Cancer Medicine Introduction
11.12.4 Takeda Revenue in Personalized Cancer Medicine Business (2016-2021)
11.12.5 Takeda Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Personalized Cancer Medicine Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Monoclonal Antibodies
Table 3. Key Players of Personalized Cancer Vaccines
Table 4. Key Players of Other
Table 5. Global Personalized Cancer Medicine Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Personalized Cancer Medicine Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Personalized Cancer Medicine Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global Personalized Cancer Medicine Market Share by Regions (2016-2021)
Table 9. Global Personalized Cancer Medicine Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global Personalized Cancer Medicine Market Share by Regions (2022-2027)
Table 11. Personalized Cancer Medicine Market Trends
Table 12. Personalized Cancer Medicine Market Drivers
Table 13. Personalized Cancer Medicine Market Challenges
Table 14. Personalized Cancer Medicine Market Restraints
Table 15. Global Personalized Cancer Medicine Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global Personalized Cancer Medicine Market Share by Players (2016-2021)
Table 17. Global Top Personalized Cancer Medicine Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Personalized Cancer Medicine as of 2020)
Table 18. Ranking of Global Top Personalized Cancer Medicine Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by Personalized Cancer Medicine Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Personalized Cancer Medicine Product Solution and Service
Table 22. Date of Enter into Personalized Cancer Medicine Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Personalized Cancer Medicine Market Size by Type (2016-2021) (US$ Million)
Table 25. Global Personalized Cancer Medicine Revenue Market Share by Type (2016-2021)
Table 26. Global Personalized Cancer Medicine Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global Personalized Cancer Medicine Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global Personalized Cancer Medicine Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global Personalized Cancer Medicine Revenue Market Share by Application (2016-2021)
Table 30. Global Personalized Cancer Medicine Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global Personalized Cancer Medicine Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America Personalized Cancer Medicine Market Size by Type (2016-2021) (US$ Million)
Table 33. North America Personalized Cancer Medicine Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America Personalized Cancer Medicine Market Size by Application (2016-2021) (US$ Million)
Table 35. North America Personalized Cancer Medicine Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America Personalized Cancer Medicine Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America Personalized Cancer Medicine Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe Personalized Cancer Medicine Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe Personalized Cancer Medicine Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe Personalized Cancer Medicine Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe Personalized Cancer Medicine Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe Personalized Cancer Medicine Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe Personalized Cancer Medicine Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific Personalized Cancer Medicine Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific Personalized Cancer Medicine Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Personalized Cancer Medicine Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific Personalized Cancer Medicine Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Personalized Cancer Medicine Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific Personalized Cancer Medicine Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America Personalized Cancer Medicine Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America Personalized Cancer Medicine Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America Personalized Cancer Medicine Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America Personalized Cancer Medicine Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America Personalized Cancer Medicine Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America Personalized Cancer Medicine Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa Personalized Cancer Medicine Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa Personalized Cancer Medicine Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Personalized Cancer Medicine Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa Personalized Cancer Medicine Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Personalized Cancer Medicine Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa Personalized Cancer Medicine Market Size by Country (2022-2027) & (US$ Million)
Table 62. Abbott Company Details
Table 63. Abbott Business Overview
Table 64. Abbott Personalized Cancer Medicine Product
Table 65. Abbott Revenue in Personalized Cancer Medicine Business (2016-2021) & (US$ Million)
Table 66. Abbott Recent Development
Table 67. Merck Company Details
Table 68. Merck Business Overview
Table 69. Merck Personalized Cancer Medicine Product
Table 70. Merck Revenue in Personalized Cancer Medicine Business (2016-2021) & (US$ Million)
Table 71. Merck Recent Development
Table 72. Novartis Company Details
Table 73. Novartis Business Overview
Table 74. Novartis Personalized Cancer Medicine Product
Table 75. Novartis Revenue in Personalized Cancer Medicine Business (2016-2021) & (US$ Million)
Table 76. Novartis Recent Development
Table 77. Amgen Company Details
Table 78. Amgen Business Overview
Table 79. Amgen Personalized Cancer Medicine Product
Table 80. Amgen Revenue in Personalized Cancer Medicine Business (2016-2021) & (US$ Million)
Table 81. Amgen Recent Development
Table 82. Celgene Company Details
Table 83. Celgene Business Overview
Table 84. Celgene Personalized Cancer Medicine Product
Table 85. Celgene Revenue in Personalized Cancer Medicine Business (2016-2021) & (US$ Million)
Table 86. Celgene Recent Development
Table 87. Bayer Company Details
Table 88. Bayer Business Overview
Table 89. Bayer Personalized Cancer Medicine Product
Table 90. Bayer Revenue in Personalized Cancer Medicine Business (2016-2021) & (US$ Million)
Table 91. Bayer Recent Development
Table 92. Roche Company Details
Table 93. Roche Business Overview
Table 94. Roche Personalized Cancer Medicine Product
Table 95. Roche Revenue in Personalized Cancer Medicine Business (2016-2021) & (US$ Million)
Table 96. Roche Recent Development
Table 97. Astellas Company Details
Table 98. Astellas Business Overview
Table 99. Astellas Revenue in Personalized Cancer Medicine Business (2016-2021) & (US$ Million)
Table 100. Astellas Recent Development
Table 101. Astrazeneca Company Details
Table 102. Astrazeneca Business Overview
Table 103. Astrazeneca Personalized Cancer Medicine Product
Table 104. Astrazeneca Revenue in Personalized Cancer Medicine Business (2016-2021) & (US$ Million)
Table 105. Astrazeneca Recent Development
Table 106. Johnson & Johnson Company Details
Table 107. Johnson & Johnson Business Overview
Table 108. Johnson & Johnson Personalized Cancer Medicine Product
Table 109. Johnson & Johnson Revenue in Personalized Cancer Medicine Business (2016-2021) & (US$ Million)
Table 110. Johnson & Johnson Recent Development
Table 111. Agilent Company Details
Table 112. Agilent Business Overview
Table 113. Agilent Personalized Cancer Medicine Product
Table 114. Agilent Revenue in Personalized Cancer Medicine Business (2016-2021) & (US$ Million)
Table 115. Agilent Recent Development
Table 116. Takeda Company Details
Table 117. Takeda Business Overview
Table 118. Takeda Personalized Cancer Medicine Product
Table 119. Takeda Revenue in Personalized Cancer Medicine Business (2016-2021) & (US$ Million)
Table 120. Takeda Recent Development
Table 121. Research Programs/Design for This Report
Table 122. Key Data Information from Secondary Sources
Table 123. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Personalized Cancer Medicine Market Share by Type: 2020 VS 2027
Figure 2. Monoclonal Antibodies Features
Figure 3. Personalized Cancer Vaccines Features
Figure 4. Other Features
Figure 5. Global Personalized Cancer Medicine Market Share by Application: 2020 VS 2027
Figure 6. Breast Cancer Case Studies
Figure 7. Lung Cancer Case Studies
Figure 8. Chronic Myeloid Leukaemia Case Studies
Figure 9. Bowel Cancer Case Studies
Figure 10. Other Cancer Case Studies
Figure 11. Personalized Cancer Medicine Report Years Considered
Figure 12. Global Personalized Cancer Medicine Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 13. Global Personalized Cancer Medicine Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 14. Global Personalized Cancer Medicine Market Share by Regions: 2020 VS 2027
Figure 15. Global Personalized Cancer Medicine Market Share by Regions (2022-2027)
Figure 16. Global Personalized Cancer Medicine Market Share by Players in 2020
Figure 17. Global Top Personalized Cancer Medicine Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Personalized Cancer Medicine as of 2020
Figure 18. The Top 10 and 5 Players Market Share by Personalized Cancer Medicine Revenue in 2020
Figure 19. Global Personalized Cancer Medicine Revenue Market Share by Type (2016-2021)
Figure 20. Global Personalized Cancer Medicine Revenue Market Share by Type (2022-2027)
Figure 21. North America Personalized Cancer Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 22. North America Personalized Cancer Medicine Market Share by Type (2016-2027)
Figure 23. North America Personalized Cancer Medicine Market Share by Application (2016-2027)
Figure 24. North America Personalized Cancer Medicine Market Share by Country (2016-2027)
Figure 25. United States Personalized Cancer Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Canada Personalized Cancer Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Personalized Cancer Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe Personalized Cancer Medicine Market Share by Type (2016-2027)
Figure 29. Europe Personalized Cancer Medicine Market Share by Application (2016-2027)
Figure 30. Europe Personalized Cancer Medicine Market Share by Country (2016-2027)
Figure 31. Germany Personalized Cancer Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. France Personalized Cancer Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. U.K. Personalized Cancer Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Italy Personalized Cancer Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Russia Personalized Cancer Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Nordic Personalized Cancer Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Personalized Cancer Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific Personalized Cancer Medicine Market Share by Type (2016-2027)
Figure 39. Asia-Pacific Personalized Cancer Medicine Market Share by Application (2016-2027)
Figure 40. Asia-Pacific Personalized Cancer Medicine Market Share by Region (2016-2027)
Figure 41. China Personalized Cancer Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Japan Personalized Cancer Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. South Korea Personalized Cancer Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Southeast Asia Personalized Cancer Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. India Personalized Cancer Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Australia Personalized Cancer Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Personalized Cancer Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America Personalized Cancer Medicine Market Share by Type (2016-2027)
Figure 49. Latin America Personalized Cancer Medicine Market Share by Application (2016-2027)
Figure 50. Latin America Personalized Cancer Medicine Market Share by Country (2016-2027)
Figure 51. Mexico Personalized Cancer Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Brazil Personalized Cancer Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Personalized Cancer Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa Personalized Cancer Medicine Market Share by Type (2016-2027)
Figure 55. Middle East & Africa Personalized Cancer Medicine Market Share by Application (2016-2027)
Figure 56. Middle East & Africa Personalized Cancer Medicine Market Share by Country (2016-2027)
Figure 57. Turkey Personalized Cancer Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Saudi Arabia Personalized Cancer Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. UAE Personalized Cancer Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. Abbott Revenue Growth Rate in Personalized Cancer Medicine Business (2016-2021)
Figure 61. Merck Revenue Growth Rate in Personalized Cancer Medicine Business (2016-2021)
Figure 62. Novartis Revenue Growth Rate in Personalized Cancer Medicine Business (2016-2021)
Figure 63. Amgen Revenue Growth Rate in Personalized Cancer Medicine Business (2016-2021)
Figure 64. Celgene Revenue Growth Rate in Personalized Cancer Medicine Business (2016-2021)
Figure 65. Bayer Revenue Growth Rate in Personalized Cancer Medicine Business (2016-2021)
Figure 66. Roche Revenue Growth Rate in Personalized Cancer Medicine Business (2016-2021)
Figure 67. Astellas Revenue Growth Rate in Personalized Cancer Medicine Business (2016-2021)
Figure 68. Astrazeneca Revenue Growth Rate in Personalized Cancer Medicine Business (2016-2021)
Figure 69. Johnson & Johnson Revenue Growth Rate in Personalized Cancer Medicine Business (2016-2021)
Figure 70. Agilent Revenue Growth Rate in Personalized Cancer Medicine Business (2016-2021)
Figure 71. Takeda Revenue Growth Rate in Personalized Cancer Medicine Business (2016-2021)
Figure 72. Bottom-up and Top-down Approaches for This Report
Figure 73. Data Triangulation
Figure 74. Key Executives Interviewed

---